Skip to Content

M 228 (Pioglitazone Hydrochloride 30 mg (base))

Pill with imprint M 228 is White, Round and has been identified as Pioglitazone Hydrochloride 30 mg (base). It is supplied by Mylan Pharmaceuticals Inc..

Pioglitazone is used in the treatment of nonalcoholic fatty liver disease; diabetes, type 2 and belongs to the drug class thiazolidinediones. Risk cannot be ruled out during pregnancy. Pioglitazone 30 mg (base) is not a controlled substance under the Controlled Substances Act (CSA).

Images for M 228

Pioglitazone Hydrochloride

Imprint:
M 228
Strength:
30 mg (base)
Color:
White
Shape:
Round
Availability:
Prescription only
Drug Class:
Thiazolidinediones
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Mylan Pharmaceuticals Inc.
Inactive Ingredients:
hydroxypropyl cellulose
lactose monohydrate
magnesium stearate
sodium lauryl sulfate
sodium starch glycolate type A potato
Note: Inactive ingredients may vary.

Other Labelers / Repackagers:

NDC CodeLabeler / Repackager
51079-0514 UDL Laboratories Inc.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide